Kessler RC, Birnbaum HG, Shahly V, Bromet E, Hwang I, McLaughlin KA, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depression Anxiety. 2010;27:351–64.

Article  PubMed  Google Scholar 

Cai H, Jin Y, Liu R, Zhang Q, Su Z, Ungvari GS, et al. Global prevalence of depression in older adults: a systematic review and meta-analysis of epidemiological surveys. Asian J Psychiatry. 2023;80:103417.

Article  Google Scholar 

Cherbuin N, Kim S, Anstey KJ. Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open. 2015;5:e008853.

Article  PubMed  PubMed Central  Google Scholar 

Lee ATC, Fung AWT, Richards M, Chan WC, Chiu HFK, Lee RSY, et al. Risk of incident dementia varies with different onset and courses of depression. J Affect Disord. 2021;282:915–20.

Article  PubMed  Google Scholar 

John A, Patel U, Rusted J, Richards M, Gaysina D. Affective problems and decline in cognitive state in older adults: a systematic review and meta-analysis. Psychological Med. 2019;49:353–65.

Article  CAS  Google Scholar 

Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572–628.

Article  PubMed  Google Scholar 

Borsini A, Zunszain PA, Thuret S, Pariante CM. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 2015;38:145–57.

Article  CAS  PubMed  Google Scholar 

Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, et al. Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases. Pharmacol Ther. 2024;258:108641.

Article  CAS  PubMed  Google Scholar 

Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135:373–87.

Article  PubMed  Google Scholar 

Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5166 patients and 5083 controls. Brain, Behavior, Immun. 2020;87:901–9.

Article  CAS  Google Scholar 

Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, et al. IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis. Sci Rep. 2018;8:12050.

Article  PubMed  PubMed Central  Google Scholar 

Gaarden TL, Engedal K, Benth JŠ, Larsen M, Lorentzen B, Mollnes TE, et al. Exploration of 27 plasma immune markers: a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons. BMC Geriatrics. 2018;18:149.

Article  PubMed  PubMed Central  Google Scholar 

van den Biggelaar AHJ, Gussekloo J, de Craen AJM, Frölich M, Stek ML, van der Mast RC, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol. 2007;42:693–701.

Article  PubMed  Google Scholar 

Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O’Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005;162:175–7.

Article  PubMed  Google Scholar 

Sobue A, Komine O, Yamanaka K. Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease. Inflamm Regen. 2023;43:26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8:359.

Article  PubMed  PubMed Central  Google Scholar 

Swardfager W, Lanctt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer’s disease. Biol Psychiatry. 2010;68:930–41.

Article  CAS  PubMed  Google Scholar 

Borza T, Engedal K, Bergh S, Benth JŠ, Selbæk G. The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients. BMC Psychiatry. 2015;15:191.

Article  PubMed  PubMed Central  Google Scholar 

Idland A-V, Sala-Llonch R, Borza T, Watne LO, Wyller TB, Brækhus A, et al. CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults. Neurobiol Aging. 2017;49:138–44.

Article  CAS  PubMed  Google Scholar 

Organization WH. ICD-10: international statistical classification of diseases and related health problems: tenth revision [Internet]. 2nd ed. Geneva PP - Geneva: World Health Organization; Available from: https://iris.who.int/handle/10665/42980

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.

Article  CAS  PubMed  Google Scholar 

Engedal K, Kvaal K, Korsnes M, Barca ML, Borza T, Selbaek G, et al. The validity of the Montgomery-Aasberg depression rating scale as a screening tool for depression in later life. J Affect Disord. 2012;141:227–32.

Article  PubMed  Google Scholar 

Xue L, Bocharova M, Young AH, Aarsland D. Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: the role of age at first onset and change in depressive symptoms. J Affect Disord. 2024;361:74–81.

Article  CAS  PubMed  Google Scholar 

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

Article  CAS  PubMed  Google Scholar 

Reimers K. Chapter Three - Evaluation of cognitive impairment. Reimers KBT-TCG to GFE. editor. Academic Press; 2019. p. 65–113.

Google Scholar 

Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19:393–4.

Article  CAS  PubMed  Google Scholar 

Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests’ norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO. Clin Neuropsychologist. 1996;10:262–78.

Article  Google Scholar 

Spreen O. A compendium of neuropsychological tests: Administration, norms, and commentary. Oxford University Press; 1998.

Google Scholar 

Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology. 1989;39:1159–65.

Article  CAS  PubMed  Google Scholar 

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, et al. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): the first twenty years. Alzheimer’s Dement. 2008;4:96–109.

Article  Google Scholar 

Newkirk LA, Kim JM, Thompson JM, Tinklenberg JR, Yesavage JA, Taylor JL. Validation of a 26-point telephone version of the mini-mental state examination. J Geriatric Psychiatry Neurol. 2004;17:81–7.

Article  Google Scholar 

Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994;24:145–53. [Internet]. 2009/07/09

Article  CAS  PubMed  Google Scholar 

Hughes CP, Berg L, Danziger W, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72. [Internet]. 2018/01/29

Article  CAS  PubMed  Google Scholar 

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-O, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.

Article  CAS  PubMed  Google Scholar 

Guy W, of Mental Health (U.S.). Psychopharmacology Research Branch. Division of Extramural Research Programs NI. ECDEU assessment manual for